Smith & Nephew is a diversified advanced medical technology business that supports healthcare professionals in more than 100 countries to improve the quality of life for their patients.
We have leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma:
- Orthopedics Reconstruction – joint replacement systems for knees, hips and shoulders
- Advanced Wound Management – wound care treatment and prevention products used to treat hard to heal wounds
- Sports Medicine – minimally invasive surgery of the joint
- Trauma & Extremities – products that help repair broken bones
We have over 16,000 employees around the world. Annual sales in 2019 were more than $5.1 billion.
We are a constituent of the UK’s FTSE100 and our shares are traded on the London Stock Exchange and through American Depository Receipts on the New York Stock Exchange (LSE: SN, NYSE: SNN) .